D
Dimitrios Daoussis
Researcher at University of Patras
Publications - 96
Citations - 2467
Dimitrios Daoussis is an academic researcher from University of Patras. The author has contributed to research in topics: Medicine & Arthritis. The author has an hindex of 22, co-authored 80 publications receiving 1921 citations. Previous affiliations of Dimitrios Daoussis include Russells Hall Hospital.
Papers
More filters
Journal ArticleDOI
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
Dimitrios Daoussis,Stamatis-Nick C. Liossis,Athanassios C. Tsamandas,Christina Kalogeropoulou,Alexandra Kazantzi,Chaido Sirinian,Maria P. Karampetsou,Georgios Yiannopoulos,Andrew P. Andonopoulos +8 more
TL;DR: The results indicate that RTX may improve lung function in patients with SSc, and it is proposed that larger scale, multicentre studies with longer evaluation periods are needed.
Journal ArticleDOI
Evidence that Dkk‐1 is dysfunctional in ankylosing spondylitis
Dimitrios Daoussis,Stamatis-Nick C. Liossis,Elena E. Solomou,Anastasia Tsanaktsi,Konstadina Bounia,Maria P. Karampetsou,Georgios Yiannopoulos,Andrew P. Andonopoulos +7 more
TL;DR: The findings indicate that in patients with AS, circulating bone formation-promoting factors functionally prevail, which can be at least partially attributed to decreased Dkk-1-mediated inhibition.
Journal ArticleDOI
A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease
Dimitrios Daoussis,Konstantinos Melissaropoulos,G Sakellaropoulos,Ioannis Antonopoulos,Theodora E. Markatseli,Theodora Simopoulou,Panagiotis Georgiou,Andrew P. Andonopoulos,Alexandros A. Drosos,Lazaros I. Sakkas,Stamatis-Nick C. Liossis +10 more
TL;DR: The data indicate that RTX has a beneficial effect on lung function and skin fibrosis in patients with SSc and Randomized controlled studies are highly needed.
Journal Article
Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis.
Dimitrios Daoussis,Stamatis-Nick C. Liossis,Athanassios C. Tsamandas,Christina Kalogeropoulou,Fotini Paliogianni,Chaido Sirinian,Georgios Yiannopoulos,Andrew P. Andonopoulos +7 more
TL;DR: It is indicated that long-term treatment with rituximab (RTX) may favourably affect lung function and skin fibrosis in patients with SSc.
Journal ArticleDOI
The Emerging Role of Dickkopf-1 in Bone Biology: Is It the Main Switch Controlling Bone and Joint Remodeling?
TL;DR: DKK-1 is a regulator of bone mass with increased expression linked to osteopenia and decreased expression to high bone mass and appears to actively participate in joint remodeling in animal models of arthritis, with increased levels related to bone resorption and decreased levels to new bone formation.